Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 14, 2024
Fusion Antibodies PLC
Total Liabilities
|
Fusion Antibodies PLC
Total Liabilities Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Total Liabilities
£604k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Liabilities
£133.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Liabilities
£31.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Total Liabilities
£5.7m
|
CAGR 3-Years
37%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Total Liabilities
£42.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Total Liabilities
£48.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
66%
|
CAGR 10-Years
40%
|
See Also
What is Fusion Antibodies PLC's Total Liabilities?
Total Liabilities
604k
GBP
604k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Liabilities amounts to 604k GBP.
What is Fusion Antibodies PLC's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
0%
0%
Over the last year, the Total Liabilities growth was -57%. The average annual Total Liabilities growth rates for Fusion Antibodies PLC have been -14% over the past three years .
You don't have any saved screeners yet
